|
Naratriptan (AmergeĀ®) occurs as triptan drug developed by Glaxo Wellcome Inc. utilized for the professional assistance of migraine headaches. Naratriptan is available inside Two.5mg tablets. These are the selective Five-hydroxytryptamine1 receptor subtype agonist. NaratriptaNorth hydrochloride is chemically intended when N-methyl-Three-( One-methyl-Four-piperidinyl)-1H-indole-Five-ethanesulfonamide.
Occasionally side results of the drug include vision changes, tingling sensations, weariness or even weakness, upset belly, lightheadedness, & warm/cold temperature sensations.
A FDA approved Amerge on February 11, 1998.
|